Live feed
Filing
SC 13G
SC 13G0000921895-22-001065·AN2 Therapeutics, Inc.
Schedule 13G ownership disclosure
AN2 Therapeutics, Inc.
Security class unavailable · CUSIP: 037326105
Event date: 2022-03-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-22-001065
- Form type
- SC 13G
- Filer
- AN2 Therapeutics, Inc.
- CIK
- CIK 1880438
- Filed
- Apr 04, 2022
- Reporting period
- Mar 25, 2022
- Description
- Schedule 13G beneficial ownership